Antibiotics | M.I.C. (Minimum inhibitory concentration) (µg) | Z.O.I (mm) Mean ± std. deviation | Sensitivity pattern n (%) | |
S | R | |||
Ampicillin | 10 | 12.01 ± 1.82 | 10 (6.5%) | 142 (92.8%) |
Amoxicillin | 20 | 11.97 ± 3.41 | 22 (14.4%) | 130 (85.0%) |
Piperacillin/Tazobactam | 100/10 | 21.67 ± 2.70 | 134 (87.6%) | 18 (11.8%) |
Cefotaxime | 30 | 21.90 ± 3.58 | 38 (24.8%) | 114 (74.5%) |
Ceftriaxone | 30 | 20.42 ± 4.20 | 50 (32.7%) | 102 (66.7%) |
Cefuroxime | 30 | 14.17 ± 4.00 | 44 (28.8 %) | 106 (69.3%) |
Ceftazidime | 30 | 17.09 ± 3.61 | 40 (26.1%) | 112 (73.2%) |
Cefoperazone/Sulbactam | 75/10 | 19.48 ± 4.66 | 108 (70.6%) | 44 (28.8%) |
Nalidixic acid | 30 | 15.12 ± 4.62 | 60 (39.2%) | 92 (60.1%) |
Ciprofloxacin | 5 | 18.93 ± 4.82 | 94 (61.4%) | 58 (37.9%) |
Levofloxacin | 5 | 15.69 ± 3.83 | 92 (60.1%) | 60 (39.2%) |
Aztreonam | 30 | 17.71 ± 3.85 | 54 (35.3%) | 98 (64.1%) |
Imipenim | 10 | 23.66 ± 1.77 | 146 (95.4%) | 6 (3.9%) |
Amikacin | 30 | 18.75 ± 1.81 | 146 (95.4%) | 6 (3.9 %) |
Gentamicin | 10 | 16.50 ± 1.81 | 142 (92.8%) | 10 (6.5%) |
Trimethoprim/ Sulfamethoxazole | 12.5/23.75 | 11.13 ± 4.92 | 54 (35.3%) | 98 (64.1%) |